Biotech | March 03, 2022
Medix Biochemica announces expansion of its porfolio
The accelerated growth of Medix Biochemica will establish its status as the ultimate IVD raw materials supplier
The accelerated growth of Medix Biochemica will establish its status as the ultimate IVD raw materials supplier
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
The acquisition of myPOLS Biotec complements Medix Biochemica’s leading portfolio of IVD raw materials and expands its reagent offerings for molecular diagnostics
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
It will be marketed under the brand name Molunamax
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
Subscribe To Our Newsletter & Stay Updated
